Interaction between genetic, lifestyle and environmental factors determining circulating angiotensin-converting enzyme 2 protein expression: implications for the severity of COVID-19 infection
Interaction between genetic, lifestyle and environmental factors determining circulating angiotensin-converting enzyme 2 protein expression: implications for the severity of COVID-19 infection
批准号:
10372177
负责人:
Kari C. Nadeau
金额:
$17.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-16 至 2023-01-13
关键词:
2019-nCoVACE2Air PollutionBiological AssayBlood PressureCOVID-19COVID-19 patientCOVID-19 severityCOVID-19 susceptibilityCardiovascular DiseasesCardiovascular systemCell LineCellsClinicalCoronavirusDataDiabetes MellitusDietDiseaseDisease susceptibilityDrug or chemical Tissue DistributionElderlyEnvironmentEnvironmental Risk FactorEpidemicEpidemiologyEpithelialEuropeFibrinogenFunctional disorderGeneral PopulationGenesGeneticHaplotypesHeritabilityIndividualInfectionInsulin ResistanceKidneyLifeLightLungMeasuresMetabolicObesityOutcomeParticipantPathway interactionsPatientsPersonsPlayPollutionPopulationPopulation StudyPredispositionProteinsRiceRiskRisk FactorsRoleSARS coronavirusSARS-CoV-2 infectionSerumSeverity of illnessSmall IntestinesSubgroupTestingTestisTissuesUnited StatesVascular EndotheliumViral Load resultWeightcardiovascular disorder preventioncardiovascular risk factorcohortdensitydisorder riskexperimental studygene environment interactiongenetic variantinsightlifestyle factorsmalemultiple omicsnovelnovel coronaviruspatient subsetspopulation basedpotential biomarkerprotein expressionreceptorrecruitresponsesevere COVID-19trait
中文摘要
总结
由新型冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病(COVID-19)已感染
全世界有1 600多万人死亡,
过去七个月几个患者亚组面临更严重的COVID-19感染风险,包括
高龄、肥胖或基础疾病(如糖尿病(DM)和心血管疾病)患者
疾病实验数据支持ACE 2受体在SARS病理生理学中的重要作用-
CoV-2感染。在流行之前,ACE 2蛋白水平一直是预测的潜在生物标志物。
预防心血管疾病和糖尿病。最近的研究表明,血清ACE 2
有心血管危险因素的患者血浆中的p53水平高于健康人。这些
研究表明升高的ACE 2水平可能是对心血管危险因素的代偿反应。
此外,据估计,高达67%的循环ACE 2水平的变异性可以解释为:
遗传因素还假设较高的ACE 2蛋白水平可能与较高的
局部病毒载量。虽然不可能测量基于人群的ACE 2受体组织密度,
研究表明,新的更灵敏的检测方法现在可以测量可溶性ACE 2(sACE 2)水平。信息的途径
基于人群的队列研究也支持sACE 2水平与风险因素平行增加的事实
与SARS-CoV-2感染的严重程度相关。在随机招募的544名参与者中,
在一般人群中,我们观察到男性、老年受试者(>55岁)和
有胰岛素抵抗的人。新出现的数据还表明,污染可能通过以下方式调节疾病风险:
增加患者易感性或激活ACE 2通路。研究与ACE 2改变相关的特征
表达及其循环水平可能揭示为什么某些人更容易感染SARS-
CoV-2感染及其潜在机制。本研究的总体目标是深入了解
ACE 2基因与环境的相互作用,因为它涉及与SARS相关的环境和生活方式因素-
通过利用独特的基于人群和COVID-19患者队列的CoV-2感染。我们假设
ACE 2的遗传变异在允许的生活方式和环境因素的存在下发挥作用,
确定sACE 2水平,因此将影响SARS-CoV-2的易感性和结局严重程度
感染我们将利用已经收集的流行病学队列和SARS-CoV-2患者队列,
美国和欧洲检测和验证一组常见的遗传变异,包括SNP和
简单和扩展的单倍型,干扰ACE 2蛋白水平及其与
环境因素包括饮食和空气污染。总的来说,我们将增加对ACE 2的了解
基因变异、ACE 2蛋白水平及其与环境因素(包括饮食和空气)的相互作用
污染,这与COVID-19疾病的易感性和严重性直接相关。
英文摘要
SUMMARY
The 2019 coronavirus disease (COVID-19) caused by the novel coronavirus 2 (SARS-CoV-2) has infected
more than 16 million people worldwide and claimed the life of more than 650,000 persons worldwide within the
past seven months. Several patient subgroups are at greater risk of more severe COVID-19 infection including
patients with advanced age, obesity, or underlying disease such as diabetes mellitus (DM) and cardiovascular
disease. Experimental data supports an important role of the ACE2 receptor in the pathophysiology of SARS-
CoV-2 infection. Prior to the epidemic, ACE2 protein levels have been a potential biomarker for the prediction
and prevention of cardiovascular diseases and diabetes. Recent studies have demonstrated that serum ACE2
level was higher in patients with cardiovascular risk factors as compared with healthy individuals. These
studies suggest that elevated ACE2 levels may be a compensatory response to cardiovascular risk factors.
Moreover, it was estimated that up to 67% of the variability in circulating ACE2 levels was explained by
heritable factors. It was also hypothesized that higher ACE2 protein level might be associated with a higher
local viral load. Although it is not possible to measure ACE2 receptor tissue density in population-based
studies, new more sensitive assays now allow the measure of soluble levels of ACE2 (sACE2). Data from our
population-based cohort also supports the fact that sACE2 levels increase in parallel with risk factors
associated with severity of SARS-CoV-2 infection. In the cohort of 544 participants randomly recruited from
the general population, we observed higher sACE2 levels in males, in older subjects (>55 years old), and in
those with insulin resistance. Emerging data also suggest that pollution may modulate risk of disease by either
increasing patient susceptibility or activating ACE2 pathways. Studying traits associated with altered ACE2
expression and its circulating levels may shed light on why certain individuals are more susceptible to SARS-
CoV-2 infection and on the underlying mechanisms. The overall objective of this study is to gain insights on the
ACE2 gene-environment interaction as it relates to environment and lifestyle factors associated with the SARS-
CoV-2 infection by leveraging unique population-based and COVID-19 patient cohorts. We hypothesize that
the genetic variants of ACE2 in the presence of permissive lifestyle and environmental factors play a role in
determining sACE2 level and therefore will impact the susceptibility and outcome severity of the SARS-CoV-2
infection. We will utilize already collected epidemiological cohorts and SARS-CoV-2 patient cohorts from the
United States and Europe to detect and validate a panel of common genetic variants, including SNPs and
simple and extended haplotypes, which interfere with the ACE2 protein level and its interaction with
environmental factors including diet and air pollution. Overall, we will increase our understanding of ACE2
gene variants, ACE2 protein level and their interaction with environmental factors, including diet and air
pollution, that are directly associated with COVID-19 disease susceptibility and severity.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1093/ajcn/nqab243
发表时间:
2021-11-08
期刊:
The American journal of clinical nutrition
影响因子:
--
作者:
[Cauwenberghs N, Prunicki M, Sabovčik F, Perelman D, Contrepois K, Li X, Snyder MP, Nadeau KC, Kuznetsova T, Haddad F, Gardner CD]
通讯作者:
Gardner CD
Clinical Core
-
批准号:10584556
-
项目类别:
-
资助金额:$27.6万
-
财政年份:2022
-
负责人:Kari C. Nadeau
-
依托单位:
Clinical Core
-
批准号:10419277
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2022
-
负责人:Kari C. Nadeau
-
依托单位:
Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)
-
批准号:10460326
-
项目类别:
-
资助金额:$212.0万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Administrative Core for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10269331
-
项目类别:
-
资助金额:$14.91万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Clinical Core
-
批准号:10491675
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Administrative Core for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10684157
-
项目类别:
-
资助金额:$25.47万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)
-
批准号:10684155
-
项目类别:
-
资助金额:$189.4万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Clinical Core
-
批准号:10687221
-
项目类别:
-
资助金额:$77.09万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Interaction between genetic, lifestyle and environmental factors determining circulating angiotensin-converting enzyme 2 protein expression: implications for the severity of COVID-19 infection
-
批准号:10228516
-
项目类别:
-
资助金额:$22.94万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Project 1 for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10684167
-
项目类别:
-
资助金额:$103.49万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Project 1 for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10269334
-
项目类别:
-
资助金额:$55.16万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Administrative Core for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10460327
-
项目类别:
-
资助金额:$14.91万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)
-
批准号:10269330
-
项目类别:
-
资助金额:$213.9万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
ConProject-004
-
批准号:10905935
-
项目类别:
-
资助金额:$6.15万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Clinical Core
-
批准号:10190559
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Project 1 for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10460330
-
项目类别:
-
资助金额:$53.28万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Immune Tolerance Dysfunction in Pregnancy due to Ambient Air Pollution Exposure
-
批准号:10225619
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2020
-
负责人:Kari C. Nadeau
-
依托单位:
Immune Tolerance Dysfunction in Pregnancy due to Ambient Air Pollution Exposure
-
批准号:10626886
-
项目类别:
-
资助金额:$42.88万
-
财政年份:2020
-
负责人:Kari C. Nadeau
-
依托单位:
Immune Tolerance Dysfunction in Pregnancy due to Ambient Air Pollution Exposure
-
批准号:10066711
-
项目类别:
-
资助金额:$39.05万
-
财政年份:2020
-
负责人:Kari C. Nadeau
-
依托单位:
Clinical-Virology Core
-
批准号:10222104
-
项目类别:
-
资助金额:$93.92万
-
财政年份:2020
-
负责人:Kari C. Nadeau
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: